Intrastriatal injection of endothelin evokes dopaminergic turning behaviour in rats through activation of the ET(B) receptor

Brain Research

Volumn 724, Issue 2, 1996, Pages 180-185

  Webber, Kim M ^a   Van Den Buuse, Maarten ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

6 Hydroxydopamine; BQ123; BQ788; Dopamine; Endothelin; Striatum; Turning behavior

Indexed keywords

APOMORPHINE; BOSENTAN; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); DOPAMINE; ENDOTHELIN 1; ENDOTHELIN 3; ENDOTHELIN A RECEPTOR; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR; ENDOTHELIN B RECEPTOR ANTAGONIST; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; OXIDOPAMINE; RACLOPRIDE TARTRATE; RECEPTOR SUBTYPE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN INJURY; CIRCLING BEHAVIOR; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINERGIC SYSTEM; DOSE RESPONSE; INTRACEREBRAL DRUG ADMINISTRATION; MALE; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; SUBCUTANEOUS DRUG ADMINISTRATION; VASOCONSTRICTION;

EID: 0030591454     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(96)00297-1     Document Type: Article

References (40)

1. Adner, M., You, J. and Edvinsson, L., Characterization of endothelin-A receptors in the cerebral circulation, Neuroreport, 4 (1993) 441-443.
2. Agnati, L.F., Zoli, M., Kurosawa, M., Benfenati, F., Biagini, G., Zini, I., Hallström, A., Ungerstedt, U., Toffano, G. and Fuxe, K., A new model of focal brain ischemia based on the intracerebral injection of endothelin-1, Ital. J. Neurol. Sci., 2 (1991) 49-53.
3. Clozel, M., Breu, V., Gray, G.A., Kalina, B., Loffler, B.M., Burri, K., Cassal, J.M., Hirth, G., Muller, M., Neidhart, W. and Ramuz, H., Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist, J. Pharmacol. Exp. Ther., 270 (1994) 228-235.
4. Deschepper, C.F., Houweling, A.D. and Picard, S., The membranes of cultured rat brain astrocytes contain endothelin-converting enzyme activity, Eur. J. Pharmacol., 275 (1995) 61-66.
5. Fuxe, K., Cintra, A., Andbjer, B., Änggård, E., Goldstein, M. and Agnati, L.F., Centrally administered endothelin-1 produces lesions in the brain of the male rat, Acta Physiol. Scand., 137 (1989) 155-156.
6. Fuxe, K., Kurosawa, N., Cintra, A., Hallström, Å., Goiny, M., Rosén, L., Agnati, L.F. and Ungerstedt, U., Involvement of local ischemia in endothelin-1 induced lesions of the neostriatum of the anesthetized rat, Exp. Brain. Res., 88 (1992) 131-139.
7. Fuxe, K., Tinner, B., Staines, W., Hemsén, A., Hersh, L. and Lundberg, J.M., Demonstration and nature of endothelin-3-like immunoreactivity in somatostatin and choline acetyltransferase-immunoreactive nerve cells of the neostriatum of the rat, Neurosci. Lett., 123 (1991) 107-111.
8. Giaid, A., Gibson, S.J., Ibrahim, N.B.N., Legon, S., Bloom, S.R., Yanagisawa, M., Masaki, T., Varndell, I.M. and Polak, J.M., Endothelin 1, an endothelium-derived peptide, is expressed in neurons of the human spinal cord and dorsal root ganglia., Proc. Natl. Acad. Sci. USA, 86 (1989) 7634-7638.
9. 2 receptors, Prog. Neuropsychopharmacol. Biol. Psychiatry, 12 (1988) 559-568.
10. Hemsén, A. and Lundberg, J.M., Presence of endothelin-1 and endothelin-3 in peripheral tissues and central nervous system of the pig, Regul. Pept., 36 (1991) 71-83.
11. Hökfelt, T. and Ungerstedt, U., Specificity of 6OHDA induced degeneration of central monoamine neurones: an electron and fluorescence microscopic study with special reference to intracerebral injection in the nigrostriatal dopamine system, Brain Res., 60 (1973) 269-297.
12. Hori, S., Komatsu, Y., Shigemoto, R., Mizuno, N. and Nakanishi, S., Distinct tissue distribution and cellular localization of two messenger ribonucleic acids encoding different subtypes of rat endothelin receptors, Endocrinology, 130 (1992) 1885-1895.
13. Horie, K., Morita, A. and Yokogoshi, H., Endothelin-1 and endothelin-3 modulate dopaminergic neurons through different mechanisms, Life Sci., 57 (1995) 735-741.
14. Huggins, J.P., Pelton, J.T. and Miller, R.C., The structure and specificity of endothelin receptors: their importance in physiology and medicine, Pharmacol. Ther., 59 (1993) 55-123.
15. Ihara, M., Noguchi, K., Saeki, T., Fukuroda, T., Tsuchida, S., Kimura, S., Fukami, T., Ishikawa, K., Nishikibe, M. and Yano, M., Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptor, Life Sci., 50 (1991) 247-255.
16. Ishikawa, K., Ihara, M., Noguchi, K., Mase, T., Mino, N., Saeki, T., Fukuroda, T., Fukami, T., Ozaki, S., Nagase, T., Nishikibe, M. and Yano, M., Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788, Proc. Natl. Acad. Sci. USA, 91 (1994) 4892-4896.
17. Jenkins, T.A., Chai, S.Y., Howells, D.W. and Mendelsohn, F.A.O., Intrastriatal angiotensin II induces turning behaviour in 6-hydroxydopamine lesioned rats, Brain Res., 691 (1995) 213-216.
18. Jones, C.R., Hiley, C.R., Pelton, J.T. and Mohr, M., Autoradiographic visualization of the binding sites for [125I]endothelin in rat and human brain, Neurosci. Lett., 97 (1989) 276-279.
19. 2+ influx to produce biphasic dopamine release from rat striatal slices, Cell. Mol. Neurobiol., 14 (1994) 271-280.
20. Kloog, Y., Ambar, I., Kochva, E., Wollberg, Z., Bdolah, A. and Sokolovsky, M., Sarafatoxin receptors mediate phosphoinositide hydrolysis in various rat brain regions, FEBS Lett., 242 (1989) 387-390.
21. Knuepfer, M.M., O'Brien, D., Hoang, D., Gan, Q. and Song, C., Central sympathetic control of spinal endothelin release in the rat, Eur. J. Pharmacol., 259 (1994) 305-308.
22. Kohzuki, M., Chai, S.Y., Paxinos, G., Karavas, A., Casley, D.J., Johnston, C.I. and Mendelsohn, F., Localization and characterization of endothelin receptor binding sites in the rat brain visualized by in vitro autoradiography, Neuroscience, 42 (1991) 245-260.
23. B receptor involvement in stimulatory and neurotoxic action of endothelin on dopamine neurones, Neuroreport, 5 (1994) 2653-2656.
24. Koizumi, S., Kataoka, Y., Niwa, M. and Kumakura, K., Endothelin-3 stimulates the release of catecholamine from cortical and striatal slices of the rat, Neurosci. Lett., 134 (1992) 219-222.
25. Koizumi, S., Kataoka, Y., Niwa, M., Watanabe, S. and Taniyama, K., Two distinct pathways are involved in the endothelin-3-evoked dopamine release from rat striatal slices., Eur. J. Pharmacol., 259 (1994) 195-201.
26. Konya, H., Nagai, K., Masuda, H. and Kakishita, E., Endothelin-3 modification of dopamine release in anesthetized rat striatum; an in vivo microdialysis study, Life Sci., 51 (1992) 499-506.
27. Kurosawa, M., Fuxe, K., Hallström, Å., Goiny, M., Cintra, A. and Ungerstedt, U., Responses of blood flow, extracellular lactate, and dopamine in the striatum to intrastriatal injection of endothelin-1 in anesthetized rats, J. Cardiovasc. Pharmacol., 17 (1991) S340-S342.
28. Lee, M.E., De la Monte, S.M., Ng, S.C., Bloch, K.D. and Quertermous, T., Expression of the potent vasoconstrictor endothelin in the human central nervous system, J. Clin. Invest., 86 (1990) 141-147.
29. MacCumber, M.W., Ross, C.A., Glaser, B.M. and Snyder, S.H., Endothelin: visualization of mRNAs by in situ hybridization provides evidence for local action, Proc. Natl. Acad. Sci. USA, 86 (1989) 7285-7289.
30. MacCumber, M.W., Ross, C.A. and Snyder, S.H., Endothelin in brain: receptors, mitogenesis, and biosynthesis in glial cells, Proc. Natl. Acad. Sci. USA, 87 (1990) 2359-2363.
31. Masaki, T., Yanagisawa, M. and Goto, M., Physiology and pharmacology of endothelins, Med. Res. Rev., 12 (1992) 391-421.
32. Matsumoto, H., Suzuki, N., Onda, H. and Fujino, M., Abundance of endothelin-3 in rat intestine, pituitary gland and brain, Biochem. Biophys. Res. Commun., 164 (1989) 74-80.
33. Paxinos, G. and Watson, C., The Rat Brain in Stereotaxic Coordinates, 2nd edn., Academic Press, New York, 1982.
34. 1,3,11,15]endothelin-1 analogs with ET-B agonistic activity, Biochem. Biophys. Res. Commun., 179 (1991) 286-292.
35. A receptors, Brain Res., 658 (1994) 179-184.
36. Ungerstedt, U., Postsynaptic supersensitivity after 6-hydroxdopamine induced degeneration of the nigro-striatal system, Acta Physiol. Scand., s367 (1971) 69-93.
37. Warner, T.D., Budzik, G.P., Matsumoto, T., Mitchell, J.A., Förstermann, U. and Murad, F., Regional differences in endothelin converting enzyme activity in rat brain: inhibition by phosphoramidon and EDTA, Br. J. Pharmacol., 106 (1992) 948-952.
38. Yamamoto, S., Inenaga, K., Kannan, H., Eto, S. and Yamashita, H., The actions of endothelin on single cells in the anteroventral third ventricular region and supraoptic nucleus in rat hypothalamic slices, J. Neuroendocrinol., 5 (1993) 427-434.
39. Yanagisawa, M., Kurihara, H., Kimura, S., Tomobe, Y., Kobayashi, M., Mitsui, Y., Yazaki, Y., Goto, K. and Masaki, T., A novel potent vasoconstrictor peptide produced by vascular endothelial cells, Nature, 332 (1988) 411-415.
40. Yoshizawa, T., Kimura, S., Kanazawa, I., Yanagisawa, M. and Masaki, T., Endothelin-1 depolarizes a ventral root potential in the newborn rat spinal cord, J. Cardiovasc. Pharmacol., 13 (1989) S216-S217.